Association of change in metabolic syndrome status with altered risk of incident gout: comment on the article by Eun et al

Article Rheumatology

Altered Risk of Incident Gout According to Changes in Metabolic Syndrome Status: A Nationwide, Population-Based Cohort Study of 1.29 Million Young Men

Yeonghee Eun et al.

Summary: This study aimed to assess the associations between metabolic syndrome and incident gout, as well as changes in the clinical characteristics of metabolic syndrome and incident gout. The results showed that individuals with chronic metabolic syndrome had a nearly 4-fold higher risk of developing gout compared to those without metabolic syndrome. Development of metabolic syndrome more than doubled the risk of gout, while recovery from metabolic syndrome reduced the risk by nearly half.

ARTHRITIS & RHEUMATOLOGY (2023)

Add to Collection

Article Rheumatology

Lower risk of gout in sodium glucose cotransporter 2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP4) inhibitors in type-2 diabetes

Jiandong Zhou et al.

Summary: This retrospective study compared the effects of SGLT2 inhibitors and DPP4 inhibitors on the risk of gout. The results showed that patients using SGLT2 inhibitors had a significantly lower incidence of gout and a lower risk of all-cause mortality compared to those using DPP4 inhibitors.

RHEUMATOLOGY (2023)

Add to Collection

Review Nutrition & Dietetics

Moving the Needle in Gout Management: The Role of Culture, Diet, Genetics, and Personalized Patient Care Practices

Youssef M. Roman

Summary: Gout is a metabolic disorder that is on the rise globally, and its development and recurrence can be influenced by factors such as diet, culture, and social determinants of health. A holistic assessment and culturally tailored dietary recommendations can help optimize treatment outcomes for gout patients. Further research is needed to understand the role of gene-diet interactions in hyperuricemia and gout.

NUTRIENTS (2022)

Add to Collection

Article Rheumatology

The prevalence of the gout-associated polymorphism rs2231142 G>T in ABCG2 in a pregnant female Filipino cohort

Youssef Roman et al.

CLINICAL RHEUMATOLOGY (2020)

Add to Collection

Article Endocrinology & Metabolism

Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study

Boris Waldman et al.

LANCET DIABETES & ENDOCRINOLOGY (2018)

Add to Collection

Article Medicine, General & Internal

Low-Level Lead Exposure and the Prevalence of Gout An Observational Study

Eswar Krishnan et al.

ANNALS OF INTERNAL MEDICINE (2012)

Add to Collection

Article Medicine, General & Internal

Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study

Hyon K. Choi et al.

BRITISH MEDICAL JOURNAL (2012)

Add to Collection

Association of change in metabolic syndrome status with altered risk of incident gout: comment on the article by Eun et al

Related references

Altered Risk of Incident Gout According to Changes in Metabolic Syndrome Status: A Nationwide, Population-Based Cohort Study of 1.29 Million Young Men

Lower risk of gout in sodium glucose cotransporter 2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP4) inhibitors in type-2 diabetes

Moving the Needle in Gout Management: The Role of Culture, Diet, Genetics, and Personalized Patient Care Practices

The prevalence of the gout-associated polymorphism rs2231142 G>T in ABCG2 in a pregnant female Filipino cohort

Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study

Low-Level Lead Exposure and the Prevalence of Gout An Observational Study

Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study

Export Citation

Share Paper